MYC and triple-negative breast carcinoma: Bowling et al. found that in MYC-driven triple-negative breast cancer, spliceosome-targeted therapy causes widespread cytoplasmic accumulation of mis-spliced dsRNA and triggers antiviral signaling and extrinsic apoptosis, which is closely related to the immune [41].